Keyphrases
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
100%
Graft-versus-host Disease (GvHD)
65%
Overall Survival
51%
Pretransplant
38%
Confidence Interval
32%
Immune Reconstitution
27%
Hematopoietic Stem Cell Transplantation
26%
Non-relapse Mortality
22%
Nonmyeloablative
20%
Myelodysplastic Syndrome
20%
Hematopoietic Cell Transplantation
19%
Natural Killer Cells
18%
Relapse-free Survival
17%
Flow Cytometry
17%
Myeloablative Conditioning
16%
Myeloablative
16%
Non-myeloablative Transplantation
16%
Extracorporeal Photopheresis
16%
Vitamin E
16%
Sexual Behavior
11%
Acute Myeloid Leukemia
11%
Immunosuppression
10%
Chronic Lymphocytic Leukemia
10%
Cyclosporine
10%
Acute Lymphoblastic Leukemia
9%
Allogeneic Transplantation
9%
Host Disease
9%
Transplantation
9%
Infliximab
9%
Hazard Ratio
8%
T-cell Replete
8%
Improved Outcomes
8%
Donor Lymphocyte Infusion
8%
Clonal Cytopenia of Undetermined Significance
8%
Vitamin D Status
8%
Improved Survival
8%
Population-based Study
8%
Strong Predictor
8%
Graft-versus-host Disease Prophylaxis
8%
Pulmonary Comorbidities
8%
Danish Population
8%
HLA-matched Donor
8%
Plasma Vitamin D
8%
Longitudinal Follow-up
8%
Primary Effusion Lymphoma
8%
Response Status
8%
Pulmonary Function
8%
Prognostic Biomarker
8%
Idiopathic Cytopenia of Undetermined Significance
8%
Treosulfan
8%
Immunology and Microbiology
Cell Transplantation
48%
Hematopoietic Cell
48%
Acute Graft Versus Host Disease
48%
Overall Survival
46%
Allogeneic Hematopoietic Stem Cell Transplantation
37%
Immune Reconstitution
27%
Allogeneic Stem Cell Transplantation
24%
T Cell
19%
Graft-Versus-Host Disease
18%
Natural Killer Cell
18%
Recurrence Free Survival
17%
Myeloid
16%
Vitamin E
16%
Hematopoietic Stem Cell Transplantation
15%
Chronic Graft Versus Host Disease
15%
Blood Plasma
12%
Lymphocyte
12%
Vitamin Blood Level
11%
Morphology
10%
Immunosuppression
9%
Allotransplantation
9%
Host
9%
Infliximab
9%
Conditioning
9%
Comorbidity
8%
C-Reactive Protein
8%
Lung Function
8%
Prognostic Biomarker
8%
Precursor
8%
Gamma Delta T-Cell
8%
T Cell Receptor
8%
Cytokine Response
8%
Leukocyte
8%
Mycophenolic Acid
6%
Transplant Procedure
6%
Granulocyte
5%
Monocyte
5%
Medicine and Dentistry
Allogeneic Hematopoietic Stem Cell Transplantation
33%
Acute Graft Versus Host Disease
32%
Overall Survival
28%
Myelodysplastic Syndrome
28%
Cell Transplantation
24%
Hematopoietic Stem Cell
24%
Graft Versus Host Reaction
17%
Cytopenia
16%
Photopheresis
16%
Alpha Tocopherol
16%
Flow Cytometry
16%
Disease
16%
T Cell
16%
Hematopoietic Stem Cell Transplantation
15%
Chronic Graft Versus Host Disease
13%
Cyclosporine
12%
Acute Myeloid Leukemia
11%
Myeloablative Conditioning
11%
Hazard Ratio
10%
Conditioning
9%
Acute Lymphoblastic Leukemia
9%
Diagnosis
9%
Bone Marrow Transplantation
9%
Allotransplantation
8%
Treosulfan
8%
Donor Lymphocyte Infusion
8%
Systematic Review
8%
Vitamin D
8%
Ibrutinib
8%
Fludarabine
8%
B-Cell Chronic Lymphocytic Leukemia
8%
Minimal Residual Disease
8%
Immunosuppressive Treatment
8%
Venetoclax
8%
Primary Effusion Lymphoma
8%
Allogeneic Stem Cell Transplantation
8%
Natural Killer Cell
8%
Prophylaxis
8%
T-Cell Lymphoma
8%
Pleura Effusion
8%
Transplantation
7%
Mycophenolic Acid
6%
Dysplasia
6%
Human Herpesvirus 8
6%
Non-Hodgkin Lymphoma
6%
Cumulative Incidence
5%
